↓ Skip to main content

Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

Overview of attention for article published in BMC Cancer, August 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study
Published in
BMC Cancer, August 2019
DOI 10.1186/s12885-019-6010-9
Pubmed ID
Authors

Derek Weycker, Robin Doroff, Ahuva Hanau, Charles Bowers, Rajesh Belani, David Chandler, Alexander Lonshteyn, Mark Bensink, Gary H. Lyman

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 11%
Other 1 5%
Student > Bachelor 1 5%
Lecturer 1 5%
Student > Master 1 5%
Other 1 5%
Unknown 12 63%
Readers by discipline Count As %
Medicine and Dentistry 3 16%
Nursing and Health Professions 3 16%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unknown 12 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2022.
All research outputs
#14,020,183
of 24,450,293 outputs
Outputs from BMC Cancer
#2,955
of 8,680 outputs
Outputs of similar age
#165,937
of 349,305 outputs
Outputs of similar age from BMC Cancer
#73
of 194 outputs
Altmetric has tracked 24,450,293 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,680 research outputs from this source. They receive a mean Attention Score of 4.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,305 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 194 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.